We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
+$146M
Cap. Flow %
3.08%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162
Avg Time Held Equity + Options
3.8 quarters
Top 10 Avg Time Held Equity + Options
1.1 quarters
Top 20 Avg Time Held Equity + Options
1.1 quarters
Avg Time Held Equity only
3.9 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.68%
3 Financials 11.99%
4 Miscellaneous 10.5%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EIGR
451
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$277K 0.01%
13,133
-937
-7% -$28.9K
2022 Q1
5 quarters
XBI icon
452
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
$268K 0.01%
130,000
-10,000
-7% -$836K
2023 Q1
1 quarter
TDC icon
453
Teradata
TDC
$2.85B
$267K 0.01%
5,000
-5,003
-50% -$226K
2023 Q1
1 quarter
SYBX icon
454
DELISTED
Synlogic
SYBX
$262K 0.01%
40,549
-1,805
-4% -$15.1K
2022 Q1
5 quarters
BBIO icon
455
CALL
BridgeBio Pharma
BBIO
$12.9B
$247K 0.01%
93,900
+4,600
+5% +$69.2K
2023 Q1
1 quarter
BMEA icon
456
PUT
Biomea Fusion
BMEA
$98.6M
$243K 0.01%
+45,000
New +$1.41M
2023 Q2
0 quarters
BGS icon
457
PUT
B&G Foods
BGS
$198M
$243K 0.01%
215,000
+150,000
+231% +$2.16M
2023 Q1
1 quarter
ORCL icon
458
Oracle
ORCL
$416B
$237K 0.01%
+1,993
New +$206K
2023 Q2
0 quarters
VERA icon
459
CALL
Vera Therapeutics
VERA
$2B
$231K ﹤0.01%
+55,000
New +$497K
2023 Q2
0 quarters
CHGG icon
460
Chegg
CHGG
$78.9M
$222K ﹤0.01%
25,000
– –
2023 Q1
1 quarter
RIG icon
461
PUT
Transocean
RIG
$6.25B
$220K ﹤0.01%
400,000
-85,000
-18% -$525K
2018 Q2
20 quarters
MAT icon
462
CALL
Mattel
MAT
$4.79B
$213K ﹤0.01%
+250,000
New +$4.52M
2023 Q2
0 quarters
AFMD icon
463
DELISTED
Affimed
AFMD
$204K ﹤0.01%
+34,090
New +$273K
2023 Q2
0 quarters
PFSI icon
464
PUT
PennyMac Financial
PFSI
$3.06B
$168K ﹤0.01%
+110,000
New +$6.97M
2023 Q2
0 quarters
AAOI icon
465
CALL
Applied Optoelectronics
AAOI
$8.55B
$165K ﹤0.01%
100,000
– –
2023 Q1
1 quarter
MNK
466
DELISTED
Mallinckrodt plc
MNK
$153K ﹤0.01%
129,376
– –
2022 Q4
2 quarters
RVLP
467
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$143K ﹤0.01%
254,736
-21,692
-8% -$19.1K
2022 Q3
3 quarters
ADT icon
468
PUT
ADT
ADT
$4.71B
$142K ﹤0.01%
35,600
– –
2021 Q2
8 quarters
RETA
469
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$133K ﹤0.01%
+16,000
New +$1.51M
2023 Q2
0 quarters
BBIO icon
470
PUT
BridgeBio Pharma
BBIO
$12.9B
$126K ﹤0.01%
36,000
-14,000
-28% -$211K
2023 Q1
1 quarter
MRSN icon
471
CALL
DELISTED
Mersana Therapeutics
MRSN
$115K ﹤0.01%
+16,600
New +$2.43M
2023 Q2
0 quarters
CNTX icon
472
Context Therapeutics
CNTX
$28M
$105K ﹤0.01%
+65,628
New +$55.8K
2023 Q2
0 quarters
IWM icon
473
PUT
iShares Russell 2000 ETF
IWM
$78.3B
$104K ﹤0.01%
340,000
-1,890,000
-85% -$337M
2023 Q1
1 quarter
MGM icon
474
PUT
MGM Resorts International
MGM
$7.38B
$102K ﹤0.01%
35,000
– –
2023 Q1
1 quarter
NVCR icon
475
CALL
NovoCure
NVCR
$1.71B
$101K ﹤0.01%
+22,000
New +$1.37M
2023 Q2
0 quarters
17 18
19
20 21

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor deployed $146M of net new capital in Q2 2023, opening 128 new positions and adding to 150 existing holdings. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Tower Semiconductor, an estimated $50.8M trimmed.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.